Annual Report 2024

other reports
Fresenius logofresenius logo

Consolidated statement of financial position

Consolidated statement of financial position

as of December 31, € in millions

 

Note

 

2024

 

2023

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

15

 

2,282

 

2,562

Trade accounts and other receivables, less allowances for expected credit losses

 

16

 

3,500

 

3,673

Inventories

 

17

 

2,573

 

2,517

Other financial assets

 

18

 

1,422

 

1,504

Other assets

 

19

 

1,145

 

1,533

Income tax receivables

 

 

 

214

 

176

Assets held for sale

 

2

 

310

 

555

I. Total current assets

 

 

 

11,446

 

12,520

Property, plant and equipment

 

20

 

8,569

 

8,964

Right-of-use assets

 

34

 

1,321

 

1,818

Goodwill

 

21

 

15,085

 

15,089

Other intangible assets

 

21

 

2,422

 

2,531

Fresenius Medical Care investment accounted for using the equity method

 

22

 

3,639

 

3,500

Other financial assets

 

18

 

426

 

360

Other assets

 

19, 22

 

231

 

142

Deferred taxes

 

11

 

411

 

360

II. Total non-current assets

 

 

 

32,104

 

32,764

Total assets

 

 

 

43,550

 

45,284

 

 

 

 

 

 

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

Trade accounts payable

 

 

 

1,359

 

1,488

Debt

 

26

 

746

 

1,061

Lease liabilities

 

34

 

172

 

206

Bonds

 

27

 

1,854

 

815

Convertible bonds

 

28

 

 

499

Other financial liabilities

 

24

 

1,549

 

1,644

Other liabilities

 

25

 

2,094

 

2,477

Provisions

 

23

 

663

 

799

Income tax liabilities

 

 

 

148

 

111

Liabilities directly associated with the assets held for sale

 

2

 

424

 

230

A. Total short-term liabilities

 

 

 

9,009

 

9,330

Debt

 

26

 

1,740

 

2,216

Lease liabilities

 

34

 

1,328

 

1,792

Bonds

 

27

 

7,737

 

9,241

Other financial liabilities

 

24

 

965

 

826

Other liabilities

 

25

 

252

 

229

Pension liabilities

 

29

 

605

 

666

Provisions

 

23

 

717

 

523

Income tax liabilities

 

 

 

280

 

279

Deferred taxes

 

11

 

627

 

531

B. Total long-term liabilities

 

 

 

14,251

 

16,303

I. Total liabilities

 

 

 

23,260

 

25,633

A. Noncontrolling interests

 

30

 

748

 

652

Subscribed capital

 

31

 

563

 

563

Capital reserve

 

31

 

4,315

 

4,326

Other reserves

 

31

 

14,038

 

14,092

Accumulated other comprehensive income

 

32

 

626

 

18

B. Total Fresenius SE & Co. KGaA shareholders’ equity

 

 

 

19,542

 

18,999

II. Total shareholders’ equity

 

 

 

20,290

 

19,651

Total liabilities and shareholders’ equity

 

 

 

43,550

 

45,284

The following notes are an integral part of the consolidated financial statements.

Tag Manager

Results for